BD Board Increases Dividend for 53rd Consecutive Year

BDXB 11.07.2024

Full Press ReleaseSEC FilingsOur BDXB Tweets

About Gravity Analytica

Recent News

  • 01.22.2025 - Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
  • 01.21.2025 - BD Appoints Tim Patz as Worldwide President of Advanced Patient Monitoring
  • 01.20.2025 - BD Highlights the Latest Innovations in Drug Delivery at Pharmapack 2025

Recent Filings

  • 01.22.2025 - 4 Statement of changes in beneficial ownership of securities
  • 01.21.2025 - 144 Report of proposed sale of securities

BD Board Increases Dividend for 53rd Consecutive Year

November 07, 2024 6:25 am ESTDownload as PDF

FRANKLIN LAKES, N.J.,Nov. 7, 2024/PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $1.04 per common share, an increase of 9.5% from the previous quarter. The dividend will be payable on December 31, 2024 to holders of record on December 9, 2024. The indicated annual dividend rate for fiscal year 2025 is $4.16 per share.

"This is the 53rdconsecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president of BD. "This increase reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value through execution of our BD 2025 strategy and return capital to shareholders."

About BDBDis one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on thefrontlinesof health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.BDand its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics.BDhas a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers,BDcan help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information onBD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X (formerly Twitter)@BDandCoor Instagram@becton_dickinson.

Contacts:

Media:

Investors:

Troy Kirkpatrick

Adam Reiffe

VP, Public Relations

Sr. Director, Investor Relations

858.617.2361

201.847.6927

troy.kirkpatrick@bd.com

adam.reiffe@bd.com

View original content:https://www.prnewswire.com/news-releases/bd-board-increases-dividend-for-53rd-consecutive-year-302298075.html

SOURCE BD (Becton, Dickinson and Company)

Released November 7, 2024

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com